Cost reduction associated with heparin-induced thrombocytopenia panel ordering for enoxaparin versus heparin for prophylactic and therapeutic use: A retrospective analysis in a community hospital setting

BACKGROUND: Most hospitals still use unfractionated heparin (UFH) as the primary agent for venous thromboembolism (VTE) prophylaxis in the hospital setting due to ease of use and insignificant cost. However, the risk of heparin-induced thrombocytopenia (HIT) has led some groups to favor other option...

Descripción completa

Detalles Bibliográficos

Autores principales:	Menon, Harry, Pillai, Adip, Aussenberg-Rodriguez, Jeanine, Ambrose, John, Youssef, Irini, Griffiths, Elizabeth A., Al Ustwani, Omar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6178568/ https://www.ncbi.nlm.nih.gov/pubmed/30319954 http://dx.doi.org/10.4103/ajm.AJM_78_18